Medpace Holdings (MEDP) Notes Payables (2022 - 2023)
Medpace Holdings (MEDP) posted Notes Payables of $55.0 million for Q2 2023, down 52.17% quarter-over-quarter from $115.0 million in Q1 2023, and down 77.97% year-on-year from $249.7 million in Q2 2022.
Medpace Holdings (MEDP) Notes Payables (2022 - 2023) Analysis & Trends
Medpace Holdings (MEDP) has reported Notes Payables for 2 consecutive years, with $55.0 million the latest figure, recorded in Q2 2023.
- Notes Payables for Q2 2023 came in at $55.0 million, down 77.97% year-over-year; the trailing twelve-month figure through Jun 2023 was $55.0 million (down 77.97% YoY), and the FY2022 annual result was $50.0 million, changed N/A from the prior year.
- Notes Payables was $55.0 million for Q2 2023 at Medpace Holdings, down from $115.0 million in the prior quarter.
- Over five years, Notes Payables peaked at $249.7 million in Q2 2022 and troughed at $50.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Medpace Holdings | 15.46 Bn | 14.81 Bn | 196.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 55.00 Mn |
| Mar 31, 2023 | 115.00 Mn |
| Dec 31, 2022 | 50.00 Mn |
| Sep 30, 2022 | 139.70 Mn |
| Jun 30, 2022 | 249.70 Mn |